A Million Person Study Innovation: Evaluating Cognitive Impairment and other Morbidity Outcomes from Chronic Radiation Exposure Through Linkages with the Centers for Medicaid and Medicare Services Assessment and Claims Data.

Autor: Dauer LT; Memorial Sloan Kettering Cancer Center, New York, New York., Mumma MT; Vanderbilt University Medical Center's International Epidemiology Field Station, Rockville, Maryland., Lima JC; Brown University School of Public Health, Providence, Rhode Island., Cohen SS; DLH, LLC, Bethesda, Maryland., Andresen D; Kansas State University, Manhattan, Kansas., Bahadori AA; Kansas State University, Manhattan, Kansas., Bellamy M; Memorial Sloan Kettering Cancer Center, New York, New York., Bierman DA; Memorial Sloan Kettering Cancer Center, New York, New York., Blattnig S; NASA Langley Research Center, Hampton, Virginia., French B; Vanderbilt University Medical Center, Nashville, Tennessee., Giunta E; Kansas State University, Manhattan, Kansas., Held K; National Council on Radiation Protection and Measurements, Bethesda, Maryland., Hertel N; Georgia Institute of Technology, Atlanta, Georgia., Keohane L; Vanderbilt University Medical Center, Nashville, Tennessee., Leggett R; Oak Ridge National Laboratory, Oak Ridge, Tennessee., Lipworth L; Vanderbilt University Medical Center, Nashville, Tennessee., Miller KB; National Institute of Aerospace, Hampton, Virginia.; Morrison Family College of Health, University of St. Thomas, Saint Paul, Minnesota., Norman RB; NASA Langley Research Center, Hampton, Virginia., Samuels C; Oak Ridge National Laboratory, Oak Ridge, Tennessee., Thomas KS; Johns Hopkins University School of Nursing, Baltimore, Maryland., Tolmachev SY; Washington State University, Richland, Washington., Walsh L; University of Zürich, Zürich, Switzerland., Boice JD Jr; National Council on Radiation Protection and Measurements, Bethesda, Maryland.; Vanderbilt University School of Medicine, Nashville, Tennessee.

Publikováno v: Radiation research [Radiat Res] 2024 Dec 01; Vol. 202 (6), pp. 847-861.

Absence of ABL1 exon 2-encoded SH3 residues in BCR::ABL1 destabilizes the autoinhibited kinase conformation and confers resistance to asciminib.

Autor: Leyte-Vidal A; Division of Hematology/Oncology, Department of Medicine, University of California, San Francisco, CA, 94143, USA.; Department of Biochemistry and Molecular Biology, University of Miami Miller School of Medicine, Miami, FL, 33101, USA., DeFilippis R; Division of Hematology/Oncology, Department of Medicine, University of California, San Francisco, CA, 94143, USA., Outhwaite IR; Department of Pharmacological Sciences, Renaissance School of Medicine, Stony Brook University, Stony Brook, NY, 11794, USA., Kwan I; Department of Pharmacological Sciences, Renaissance School of Medicine, Stony Brook University, Stony Brook, NY, 11794, USA.; Laufer Center for Physical and Quantitative Biology, Stony Brook University, Stony Brook, NY, 11794, USA.; Department of Biochemistry and Cell Biology, Renaissance School of Medicine, Stony Brook University, Stony Brook, NY, 11794, USA., Lee JY; Laufer Center for Physical and Quantitative Biology, Stony Brook University, Stony Brook, NY, 11794, USA., Leavitt C; Division of Hematology/Oncology, Department of Medicine, University of California, San Francisco, CA, 94143, USA., Miller KB; Division of Hematology/Oncology, Department of Medicine, University of California, San Francisco, CA, 94143, USA., Rea D; Adult Hematology Department, Hôpital Saint-Louis, Paris, France., Rangwala AM; Department of Pharmacological Sciences, Renaissance School of Medicine, Stony Brook University, Stony Brook, NY, 11794, USA., Lou K; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA, 94158, USA.; Howard Hughes Medical Institute, University of California, San Francisco, CA, 94158, USA., Patel S; Division of Hematology/Oncology, Department of Medicine, University of California, San Francisco, CA, 94143, USA., Alvarez A; Division of Hematology/Oncology, Department of Medicine, University of California, San Francisco, CA, 94143, USA., Shokat KM; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA, 94158, USA.; Howard Hughes Medical Institute, University of California, San Francisco, CA, 94158, USA.; Department of Chemistry, University of California, Berkeley, CA, 94720, USA., Bahar I; Laufer Center for Physical and Quantitative Biology, Stony Brook University, Stony Brook, NY, 11794, USA.; Department of Biochemistry and Cell Biology, Renaissance School of Medicine, Stony Brook University, Stony Brook, NY, 11794, USA., Seeliger MA; Department of Pharmacological Sciences, Renaissance School of Medicine, Stony Brook University, Stony Brook, NY, 11794, USA.; Laufer Center for Physical and Quantitative Biology, Stony Brook University, Stony Brook, NY, 11794, USA., Shah NP; Division of Hematology/Oncology, Department of Medicine, University of California, San Francisco, CA, 94143, USA. neil.shah@ucsf.edu.

Publikováno v: Leukemia [Leukemia] 2024 Sep; Vol. 38 (9), pp. 2046-2050. Date of Electronic Publication: 2024 Jul 31.

BCR::ABL1 kinase N-lobe mutants confer moderate to high degrees of resistance to asciminib.

Autor: Leyte-Vidal A; Division of Hematology/Oncology, Department of Medicine, University of California, San Francisco, CA.; Department of Biochemistry and Molecular Biology, University of Miami Miller School of Medicine, Miami, FL., Garrido Ruiz D; Department of Pharmaceutical Chemistry, University of California, San Francisco, CA., DeFilippis R; Division of Hematology/Oncology, Department of Medicine, University of California, San Francisco, CA., Leske IB; Institute for Physiological Chemistry, Philipps University of Marburg, Marburg, Germany., Rea D; Adult Hematology Department, Hôpital Saint-Louis, Paris, France., Phan S; Division of Hematology/Oncology, Department of Medicine, University of California, San Francisco, CA., Miller KB; Division of Hematology/Oncology, Department of Medicine, University of California, San Francisco, CA., Hu F; Division of Hematology/Oncology, Department of Medicine, University of California, San Francisco, CA., Mase A; Division of Hematology/Oncology, Department of Medicine, University of California, San Francisco, CA., Shan Y; Antidote Health Foundation for Cure of Cancer, Cambridge, MA., Hantschel O; Institute for Physiological Chemistry, Philipps University of Marburg, Marburg, Germany., Jacobson MP; Department of Pharmaceutical Chemistry, University of California, San Francisco, CA., Shah NP; Division of Hematology/Oncology, Department of Medicine, University of California, San Francisco, CA.

Publikováno v: Blood [Blood] 2024 Aug 08; Vol. 144 (6), pp. 639-645.

Early Definitive Fixation of Talus Fractures Is Safe: A Retrospective Review.

Autor: DeGenova DT; The Department of Orthopedics, OhioHealth System, Columbus, Ohio., Miller KB; The Department of Orthopedics, OhioHealth System, Columbus, Ohio., Paulini AS; The Department of Orthopedics, OhioHealth System, Columbus, Ohio., Melaragno AJ; The Department of Orthopedics, OhioHealth System, Columbus, Ohio., Davis T; Heritage College of Osteopathic Medicine, Ohio University, Athens, Ohio., Hoffman B; College of Medicine, The University of Toledo, Toledo, Ohio., Taylor BC; Orthopedic Trauma and Reconstructive Surgeons, OhioHealth Grant Medical Center, Columbus, Ohio.

Publikováno v: Foot & ankle specialist [Foot Ankle Spec] 2023 Dec 14, pp. 19386400231218333. Date of Electronic Publication: 2023 Dec 14.

Interactive Effects of PD-L1 Expression in Tumor and Immune Cells on Prognosis of Esophageal Squamous Cell Carcinoma: A One-Center Retrospective Cohort Study

Autor: Shi F, Xiao S, Miller KB, Zhao Y, Li Y, Gao Y, Chang H, Song Q, Qu C

Publikováno v: OncoTargets and Therapy, Vol Volume 13, Pp 6565-6572 (2020)

Feng Shi,1 Shuo Xiao,2 Kaeli B Miller,2 Yanjie Zhao,3 Yuchen Li,4 Ying Gao,1 Hong Chang,1 Qingkun Song,5,6 Chenxu Qu7 1Department of Pathology, Beijing Shijitan Hospital, Capital Medical University, Beijing 100038, People’s Republic of China; 2Depa

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doajarticles::6d745e16c369e0d093b757e8d4bb495b
https://www.dovepress.com/interactive-effects-of-pd-l1-expression-in-tumor-and-immune-cells-on-p-peer-reviewed-article-OTT